AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05487300 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06194565 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05007418 — Biomarker: CD38 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD38
Study NCT05827328 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT05199636 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05199636 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study NCT06652412 — Biomarker: CGA mRNA
Type: Predictive Biomarker (PRD)
Genes: CGA
Study NCT06652412 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study NCT05491837 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study NCT06561412 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06561412 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05230446 — Biomarker: LAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: LAD1; LAD
Study NCT04696809 — Biomarker: TNFRSF17 mRNA
Type: Predictive Biomarker (PRD)
Genes: TNFRSF17; BCM; BCMA
Study NCT06027424 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05256836 — Biomarker: REM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: REM1; GES; REM
Study NCT04285671 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06025903 — Biomarker: Mitochondrial DNA
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study NCT05387785 — Biomarker: ANG mRNA
Type: Predictive Biomarker (PRD)
Genes: ANG; RNASE5
Study NCT05153603 — Biomarker: BRCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA1; RNF53
Study NCT05262660 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06493448 — Biomarker: GCLM mRNA
Type: Predictive Biomarker (PRD)
Genes: GCLM; GLCLR
Study NCT06538870 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study NCT06505252 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT06558565 — Biomarker: AGA mRNA
Type: Predictive Biomarker (PRD)
Genes: AGA
Study NCT05700851 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study NCT05124028 — Biomarker: Tyrosine-protein kinase BTK
Type: Pharmacodynamic Biomarker (PDY)
Genes: BTK; AGMX1; ATK; BPK
Study NCT05000593 — Biomarker: MSC mRNA
Type: Predictive Biomarker (PRD)
Genes: MSC; ABF1; BHLHA22
Study NCT06628180 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06720220 — Biomarker: Salivary secretion
Type: Pharmacodynamic Biomarker (PDY)
Study NCT06720272 — Biomarker: RHD mRNA
Type: Predictive Biomarker (PRD)
Genes: RHD
Study NCT05262244 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study NCT06096506 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06096506 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study NCT05982847 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06261567 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study NCT05108428 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study NCT05655260 — Biomarker: TP53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: p53; LFS1
Study NCT06442969 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05364073 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05364073 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05364073 — Biomarker: Epidermal growth factor
Type: Monitoring Biomarker (MOI)
Genes: EGF
Study NCT05081167 — Biomarker: REL mRNA
Type: Predictive Biomarker (PRD)
Genes: REL
Study NCT06326008 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT06326008 — Biomarker: CD22 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD22; SIGLEC2
Study NCT04734015 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT04711044 — Biomarker: TRPM8 mRNA
Type: Predictive Biomarker (PRD)
Genes: TRPM8; LTRPC6; TRPP8
Study NCT05174260 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05069597 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study NCT05438511 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study NCT05910879 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT04430673 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study NCT06181123 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study NCT05159726 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05159687 — Biomarker: Cytochrome P450 2D6
Type: Safety Biomarker (SAF)
Genes: CYP2D6; CYP2DL1
Study NCT05159687 — Biomarker: COMT mRNA
Type: Predictive Biomarker (PRD)
Genes: COMT
Study NCT05159687 — Biomarker: 5HTT
Type: Predictive Biomarker (PRD)
Genes: SLC6A4; 5-HTT; SERT1
Study NCT05159687 — Biomarker: SLC6A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study NCT00002004 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study NCT05963282 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study NCT05487209 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study NCT04764097 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study NCT05657080 — Biomarker: Trefoil factor 3
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TFF3; ITF; TFI
Study NCT06516146 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT00002297 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study NCT05228808 — Biomarker: Programmed cell death 1 ligand 1
Type: Predictive Biomarker (PRD)
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04975386 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05973500 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study NCT05544357 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06433869 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study NCT06433869 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study NCT05809284 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT00194961 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study NCT00194961 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study NCT04056910 — Biomarker: IDH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: IDH1; PICD
Study NCT05499312 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study NCT05350111 — Biomarker: CAMP mRNA
Type: Predictive Biomarker (PRD)
Genes: CAMP; CAP18; FALL39; HSD26
Study NCT05849389 — Biomarker: CNP mRNA
Type: Predictive Biomarker (PRD)
Genes: CNP
Study NCT05849389 — Biomarker: Annualized growth velocity
Type: Surrogate Endpoint (SUR)
Study NCT04739319 — Biomarker: AMD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AMD1; AMD
Study NCT05351762 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study NCT06334783 — Biomarker: Tumor-infiltrating lymphocyte
Type: Predictive Biomarker (PRD)
Study NCT05420077 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study NCT02968953 — Biomarker: SLC2A1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC2A1; GLUT1
Study NCT05571540 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT05116579 — Biomarker: Circulating tumor DNA
Type: Monitoring Biomarker (MOI)
Study NCT05061771 — Biomarker: Complement C5
Type: Pharmacodynamic Biomarker (PDY)
Genes: C5; CPAMD4
Study NCT05268900 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05083962 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05303636 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study NCT00433095 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04916340 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study NCT06206616 — Biomarker: Tissue transglutaminase
Type: Monitoring Biomarker (MOI)
Genes: TGM2
Study NCT05955729 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05832320 — Biomarker: RARA mRNA
Type: Predictive Biomarker (PRD)
Genes: RARA; NR1B1
Study NCT05270889 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05208255 — Biomarker: DCD mRNA
Type: Predictive Biomarker (PRD)
Genes: DCD; AIDD; DSEP
Study NCT05988385 — Biomarker: OAT mRNA
Type: Predictive Biomarker (PRD)
Genes: OAT
Study NCT06716970 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06716281 — Biomarker: MSC mRNA
Type: Predictive Biomarker (PRD)
Genes: MSC; ABF1; BHLHA22
Study NCT05541172 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study NCT05746676 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT04994418 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT00050518 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study NCT05989763 — Biomarker: SCT mRNA
Type: Predictive Biomarker (PRD)
Genes: SCT
Study NCT06504043 — Biomarker: PCSK9 mRNA
Type: Predictive Biomarker (PRD)
Genes: PCSK9; NARC1; PSEC0052
Study NCT04655391 — Biomarker: BCR mRNA
Type: Predictive Biomarker (PRD)
Genes: BCR; BCR1; D22S11
Study NCT04655391 — Biomarker: Tyrosine-protein kinase ABL1
Type: Pharmacodynamic Biomarker (PDY)
Genes: ABL1; ABL; JTK7
Study NCT06156488 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT06013865 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study NCT05711953 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT06167512 — Biomarker: HK2 mRNA
Type: Predictive Biomarker (PRD)
Genes: HK2
Study NCT06167512 — Biomarker: Hemoglobin scavenger receptor
Type: Safety Biomarker (SAF)
Genes: CD163; M130
Study NCT06167512 — Biomarker: Heme oxygenase 1
Type: Monitoring Biomarker (MOI)
Genes: HMOX1; HO; HO1
Study NCT06167512 — Biomarker: Mitochondrial membrane potential
Type: Pharmacodynamic Biomarker (PDY)
Study NCT05163600 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05933395 — Biomarker: CDK4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CDK4
Study NCT05933395 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05908513 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study NCT05241106 — Biomarker: FLT3 mRNA
Type: Predictive Biomarker (PRD)
Genes: FLT3; CD135; FLK2; STK1
Study NCT04907656 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study NCT06134648 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study NCT06198868 — Biomarker: Circulating tumor DNA
Type: Monitoring Biomarker (MOI)
Study NCT06636773 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06499155 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study NCT06549270 — Biomarker: miR-34a
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: MIR34A
Study NCT06549270 — Biomarker: miR-30a
Type: Safety Biomarker (SAF)
Genes: MIR30A
Study NCT06549270 — Biomarker: miR-155
Type: Safety Biomarker (SAF)
Genes: MIR155
Study NCT06585059 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05119205 — Biomarker: Neutrophil to lymphocyte
Type: Safety Biomarker (SAF)
Study NCT04758780 — Biomarker: Carbonic anhydrase IX
Type: Predictive Biomarker (PRD)
Genes: CA9; G250; MN
Study NCT05755048 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001105 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study NCT05187715 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study NCT05130177 — Biomarker: TIGIT mRNA
Type: Predictive Biomarker (PRD)
Genes: TIGIT; VSIG9; VSTM3
Study NCT06462768 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study NCT04916847 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study NCT04952402 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study NCT05606094 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02438202 — Biomarker: Microtubule-associated protein tau
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02438202 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study NCT02438202 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study NCT05376124 — Biomarker: ETV1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ETV1; ER81
Study NCT05376124 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study NCT06504901 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study NCT05813145 — Biomarker: Nerve growth factor
Type: Predictive Biomarker (PRD)
Genes: NGF; NGFB
Study NCT05813145 — Biomarker: Neurofilament light polypeptide
Type: Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: NEFL; NF68; NFL
Study NCT06033001 — Biomarker: Glutamate carboxypeptidase II
Type: Predictive Biomarker (PRD)
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04859023 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT06043089 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study NCT05274971 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05175430 — Biomarker: SLC6A4 mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: SLC6A4; HTT; SERT
Study NCT03541889 — Biomarker: FLT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03541889 — Biomarker: TK1 mRNA
Type: Predictive Biomarker (PRD)
Genes: TK1
Study NCT05188690 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT06210178 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06254586 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05380804 — Biomarker: 14-3-3 protein sigma
Type: Predictive Biomarker (PRD)
Genes: SFN; HME1
Study NCT05823961 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT04967833 — Biomarker: Tumor-infiltrating lymphocyte
Type: Predictive Biomarker (PRD)
Study NCT06208033 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04838613 — Biomarker: Glutamate carboxypeptidase II
Type: Predictive Biomarker (PRD)
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06431490 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05765240 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT06219512 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05077397 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT04693234 — Biomarker: TIGIT mRNA
Type: Predictive Biomarker (PRD)
Genes: TIGIT; VSIG9; VSTM3
Study NCT02588807 — Biomarker: IGFALS mRNA
Type: Predictive Biomarker (PRD)
Genes: IGFALS; ALS
Study NCT05666492 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT04984798 — Biomarker: Glutamate dehydrogenase
Type: Safety Biomarker (SAF)
Study NCT05484739 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05313594 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study NCT06020495 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study NCT05924295 — Biomarker: FGF21 mRNA
Type: Predictive Biomarker (PRD)
Genes: FGF21; UNQ3115/PRO10196
Study NCT04194671 — Biomarker: MSC mRNA
Type: Predictive Biomarker (PRD)
Genes: MSC; ABF1; BHLHA22
Study NCT05316753 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study NCT05885607 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study NCT05033158 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT05673512 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05409456 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06384040 — Biomarker: Pentraxin-related protein PTX3
Type: Safety Biomarker (SAF)
Genes: PTX3; TNFAIP5; TSG14
Study NCT06384040 — Biomarker: DPP3 mRNA
Type: Predictive Biomarker (PRD)
Genes: DPP3
Study NCT05322876 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT04988724 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05951504 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study NCT05951504 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study NCT05196165 — Biomarker: GNE mRNA
Type: Predictive Biomarker (PRD)
Genes: GNE; GLCNE
Study NCT05029440 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study NCT04798001 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study NCT06503224 — Biomarker: TNFRSF17 mRNA
Type: Predictive Biomarker (PRD)
Genes: TNFRSF17; BCM; BCMA
Study NCT06503224 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT06367725 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study NCT06243991 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT05258175 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study NCT05234151 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05037591 — Biomarker: PGC mRNA
Type: Predictive Biomarker (PRD)
Genes: PGC
Study NCT06248632 — Biomarker: Fibroblast growth factor 23
Type: Pharmacodynamic Biomarker (PDY)
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06248632 — Biomarker: PHEX mRNA
Type: Predictive Biomarker (PRD)
Genes: PHEX; PEX
Study NCT06501768 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study NCT06501768 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study NCT04853511 — Biomarker: PLXNA2 mRNA
Type: Predictive Biomarker (PRD)
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT06395454 — Biomarker: Procalcitonin
Type: Monitoring Biomarker (MOI)
Study NCT05087212 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study NCT05087212 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study NCT06554366 — Biomarker: Bacterial count
Type: Surrogate Endpoint (SUR)
Study NCT05488314 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study NCT04953468 — Biomarker: ANXA2 mRNA
Type: Predictive Biomarker (PRD)
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT06508125 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study NCT06585345 — Biomarker: CD7 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD7
Study NCT05412654 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT05513066 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT06245330 — Biomarker: AKR1C3 mRNA
Type: Predictive Biomarker (PRD)
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT05295862 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study NCT04741984 — Biomarker: O-6-methylguanine-DNA-alkyltransferase
Type: Predictive Biomarker (PRD)
Genes: MGMT
Study NCT04190550 — Biomarker: MDM2 mRNA
Type: Predictive Biomarker (PRD)
Genes: MDM2
Study NCT05512988 — Biomarker: MSC mRNA
Type: Predictive Biomarker (PRD)
Genes: MSC; ABF1; BHLHA22
Study NCT05512988 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study NCT04741646 — Biomarker: Fibroblast growth factor 23
Type: Pharmacodynamic Biomarker (PDY)
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04741646 — Biomarker: Serum phosphate
Type: Pharmacodynamic Biomarker (PDY)
Study NCT06193889 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT05145452 — Biomarker: Survival motor neuron protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06721598 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT06720532 — Biomarker: Glutamate carboxypeptidase II
Type: Predictive Biomarker (PRD)
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06720532 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study NCT05295043 — Biomarker: CDK4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CDK4
Study NCT05295043 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study NCT05295043 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05963217 — Biomarker: B-lymphocyte surface antigen B4
Type: Predictive Biomarker (PRD)
Genes: CD19
Study NCT06066554 — Biomarker: NLRP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study NCT06066554 — Biomarker: NLRP3 mRNA
Type: Predictive Biomarker (PRD)
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06066554 — Biomarker: Interleukin 18
Type: Safety Biomarker (SAF)
Genes: IL18; IGIF; IL1F4
Study NCT05769881 — Biomarker: CRH mRNA
Type: Predictive Biomarker (PRD)
Genes: CRH
Study NCT05769881 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study NCT06034470 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study NCT06034470 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study NCT05552950 — Biomarker: SARS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SARS1; SARS; SERS
Study NCT05659797 — Biomarker: FES mRNA
Type: Predictive Biomarker (PRD)
Genes: FES; FPS
Study NCT05659797 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study NCT05756946 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study NCT05070598 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04682015 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)